Sugi Predict

Sugi Predict / Compounds / SCHEMBL9988254

SCHEMBL9988254

SCHEMBL9988254

O=C(O)c1cc(O)cc(I)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 5/20 0.68
▸ CA1 P00915 5/20 0.68
▸ CA2 P00918 5/20 0.68
▸ CA9 Q16790 5/20 0.68
▸ CA7 P43166 4/20 0.68
▸ CA14 Q9ULX7 4/20 0.68
▸ HCAR1 Q9BXC0 3/20 0.56
▸ TPMT P51580 5/20 0.50
▸ CA6 P23280 4/20 0.46
▸ CA5A P35218 4/20 0.46
▸ CA3 P07451 3/20 0.46
▸ CA4 P22748 3/20 0.46
▸ CA5B Q9Y2D0 3/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1951073 0.85 TPMT (0.59) CA12CA1CA2CA9CA7
SCHEMBL422824 0.85 TPMT (0.59) CA12CA1CA2CA9CA7
3,5-Dihydroxybenzoic Acid SCHEMBL28106 0.82 CA12 (1.00) CA12CA1CA2CA9CA7
SCHEMBL139644 0.82 CA12 (0.88) CA12CA1CA2CA9CA7
3,5-Dihydroxybenzoic Acid SCHEMBL618767 0.82 CA12 (1.00) CA12CA1CA2CA9CA7
SCHEMBL9178343 0.79 CA12 (0.83) CA12CA1CA2CA9CA7
SCHEMBL9178351 0.79 CA12 (0.83) CA12CA1CA2CA9CA7
3,5-Dihydroxybenzoic Acid SCHEMBL9693437 0.79 CA12 (0.94) CA12CA1CA2CA9CA7
3,5-Dihydroxybenzoic Acid SCHEMBL1151737 0.79 CA12 (0.94) CA12CA1CA2CA9CA7
Methane SCHEMBL6131088 0.79 CA12 (0.83) CA12CA1CA2CA9CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150290344-A1 BIODEGRADABLE POLYESTER- AND POLY(ESTER AMIDE) BASED X-RAY IMAGING AGENTS CLEMSON UNIVERSITY RESEARCH FOUNDATION 2015-10-15 — — US claimed
WO-2023150197-A1 ARYL HYDROCARBON RECEPTOR AGONISTS AND USES THEREOF NEXYS THERAPEUTICS, INC. (US) 2023-08-10 — — WO disclosed
US-11579526-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-02-14 — — US disclosed
EP-3353161-B1 TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS US HEALTH (US) 2021-07-21 — — EP disclosed
CN-108271370-B As P2Y14Triazole derivatives as receptor antagonists (由卫生与公众服务部部长代表的)美利坚合众国 2021-03-19 — — CN disclosed
US-20200301274-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-09-24 — — US disclosed
US-10683277-B2 Triazole derivatives as P2Y14 receptor antagonists THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2020-06-16 — — US disclosed
CN-106457160-B Composite polyamide membrane post-treated with nitrous acid 陶氏环球技术有限责任公司 2019-10-08 — — CN disclosed
US-20180297981-A1 TRIAZOLE DERIVATIVESAS P2Y14 RECEPTOR ANTAGONISTS THE UNITED STATES OF AMERICA,AS REPRESENTED BY THE SECRETARY,DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2018-10-18 — — US disclosed
EP-3353161-A1 TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS The U.S.A. As Represented By The Secretary, Department Of Health And Human Services (US) 2018-08-01 — — EP disclosed
WO-2017053769-A1 TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2017-03-30 — — WO disclosed
US-20170065938-A1 COMPOSITE POLYAMIDE MEMBRANE POST-TREATED WITH NITROUS ACID DOW GLOBAL TECHNOLOGIES LLC (US) 2017-03-09 — — US disclosed
CN-106457160-A Composite polyamide membrane post-treated with nitrous acid 陶氏环球技术有限责任公司 2017-02-22 — — CN disclosed
WO-2015175254-A1 COMPOSITE POLYAMIDE MEMBRANE POST-TREATED WITH NITROUS ACID DOW GLOBAL TECHNOLOGIES LLC (US) 2015-11-19 — — WO disclosed
US-20150290344-A1 BIODEGRADABLE POLYESTER- AND POLY(ESTER AMIDE) BASED X-RAY IMAGING AGENTS CLEMSON UNIVERSITY RESEARCH FOUNDATION 2015-10-15 — — US disclosed
EP-2391658-B1 MOLECULARLY IMPRINTED POLYMERS COMMW SCIENT IND RES ORG (AU) 2015-09-23 — — EP disclosed
WO-2011158149-A1 2-(3,5-DISUBSTITUTEDPHENYL)PYRIMIDIN-4(3H)-ONE DERIVATIVES PFIZER INC. (US) 2011-12-22 — — WO disclosed
WO-2011158149-A1 2-(3,5-DISUBSTITUTEDPHENYL)PYRIMIDIN-4(3H)-ONE DERIVATIVES PFIZER INC. (US) 2011-12-22 — — WO disclosed
CN-1939951-B Production of aryl-alkyl-substituted hydroxy-benzoic acid resin multivalent metal salt RUIFENG CHEMICAL CO LTD XINXIANG 2010-05-12 — — CN disclosed
CN-1939951-A Production of aryl-alkyl-substituted hydroxy-benzoic acid resin multivalent metal salt RUIFENG CHEMICAL CO LTD XINXIA (CN) 2007-04-04 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150290344-A1 BIODEGRADABLE POLYESTER- AND POLY(ESTER AMIDE) BASED X-RAY IMAGING AGENTS PUF60, ARG1, PAM CA12 1978/4885CA1 3467/4885CA2 4842/4885
US-20180297981-A1 TRIAZOLE DERIVATIVESAS P2Y14 RECEPTOR ANTAGONISTS GPR119, P2RY14, P2RY4 CA12 4806/4885CA1 4585/4885CA2 3754/4885
US-10683277-B2 Triazole derivatives as P2Y14 receptor antagonists GPR119, P2RY14, P2RY4 CA12 4817/4885CA1 4636/4885CA2 3855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.